Gestational diabetes develops during pregnancy (gestation). Like other types of diabetes, gestational diabetes affects how your cells use sugar (glucose). Gestational diabetes causes high blood sugar that can affect your pregnancy and your baby’s health. Expectant women can help control gestational diabetes by eating healthy foods, exercising and, if necessary, taking medication such as insulin
When a patient experiences a blood clot in the leg (deep venous thrombosis) or of the lungs (pulmonary embolism), these can be life-threatening emergencies. Women with a history of a blood clot are at increased risk of recurrence during pregnancy. However, that risk is influenced by the circumstances surrounding the original blood clot. For example,
Thrombophilias are conditions that put people at a higher risk of developing blood clots. These blood clots can form in the veins in your legs or in your lungs. There are two types of thrombophilias: genetic ones that you can inherit from your parents and acquired ones that can develop over your lifetime. The inherited
Hepatitis B virus (HBV) infection during pregnancy presents unique management issues for both the mother and the fetus. These include the effects of HBV on maternal and fetal health, the effects of pregnancy on the course of HBV infection, treatment of HBV during pregnancy, and prevention of mother-to-child transmission. Prevention of mother-to-child transmission (vertical transmission)
What is Cell-Free DNA Screening? Cell-free DNA or cfDNA, refers to the fragments of fetal DNA found in the mother’s blood during a pregnancy. cfDNA is particularly helpful in conducting tests regarding the developing fetus during pregnancies in a minimally invasive way. The majority of the cfDNA found in the blood comes from the placenta
In preparation for pregnancy, it is important to know about the potential risks and conditions that can occur with pregnancy, how to spot them, and when to seek treatment. Fibroids are the most common benign gynecological tumors and can be found in 1%-10% of women during pregnancy according to the Society for Maternal Fetal Medicine.